Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0123-2021Class I

Spectrum IQ Infusion System with Dose IQ Safety Software

Baxter Healthcare Corporation / initiated 2020-06-30 / Terminated / root cause: labeling and UDI

Baxter Healthcare Corporation began a recall of Spectrum IQ Infusion System with Dose IQ Safety Software on . FDA classified it as Class I and gives the reason as "Baxter is updating the device IFU for safety communication regarding cleaning practices". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-0123-2021
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Baxter Healthcare Corporation
Product
Spectrum IQ Infusion System with Dose IQ Safety Software
Product code
FRN Pump, Infusion
Reason for recall
Baxter is updating the device IFU for safety communication regarding cleaning practices.
Root cause tag
labeling and UDI
FDA root cause
Labeling design
Action
A Safety Alert communication was sent to affected customers on 04/01/2020 via USPS First Class Mail. A follow-up Urgent Device Correction communication was sent to all affected customers on 8/28/2020 via USPS first class mail. The customer communications reiterate instructions for use listed in the Operator's Manual. Baxter is asking customers to: 1) Operators may continue to safely use the infusion pumps while following the instructions for cleaning provided in the Operator's Manual. An electronic copy of the Operator's Manual can be accessed at https://service.baxter.com. In addition, a full list of approved cleaning agents can be accessed at www.spectrumIQ.com/resources.html. 2) Inspect all pumps at their facility to assess the electrical pins on the pump rear case and the battery electrical contacts for residue buildup or corrosion. If corrosion or residue buildup is identified, please contact Baxter to service the device. 3) Baxter will be updating the Instructions for Use to recommend a routine inspection process for the electrical pins on the pump rear case and the battery electrical contacts. Once the updated Instructions for Use are made available, Baxter will issue a written notification to inform customers of the availability of the updated IFU. The updated IFU may be accessed online at the Baxter Global Technical E Service Center at URL: https://service.baxter.com. 4) Clinicians should ensure backup devices are readily available when infusing critical medications where interruptions could cause serious injury or death. 5) To maintain the battery properly, please ensure the pumps are plugged into AC power when possible to prevent battery depletion. 6) Complete the enclosed customer reply form and return it to Baxter by email. On 9/22/2021, the firm issued an Urgent Device Correction letter dated 9/22/2021 in follow-up to their communication of the 4/1/2020 safety alert and 8/28/2020 Urgent Device Correction. This was issued via first class USPS ma
Quantity in commerce
146,224 units
Distribution
Distribution throughout the United States, St. Thomas USVI, and Puerto Rico. Foreign distribution including Canada, Caribbean (Barbados, Trinidad and Tobago, Jamaica, Bahamas, Bermuda, and Guyana)
Product codes and lots
Product Code: 3570009, All Serial Numbers; GTIN 00085412610900

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0123-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0120-2021Class ITerminatedVoluntary: Firm initiated
Z-0121-2021Class ITerminatedVoluntary: Firm initiated
Z-0122-2021Class ITerminatedVoluntary: Firm initiated
Z-0123-2021Class ITerminatedVoluntary: Firm initiated